Oxytocin Administration in BDD and OCD

NCT02671266 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Body Dysmorphic Disorder
Obsessive-compulsive Disorder

Interventions

DRUG: Oxytocin
DRUG: Placebo

Sponsor

Massachusetts General Hospital